S&P/ASX 200 Index (ASX: XJO) shares closed 0.46% lower on Wednesday at 8,630.4 points.
Within the 11Â market sectors, consumer discretionary shares rose the most, up 2.9% yesterday.
Materials shares also had a strong day after BHP Group Ltd (ASX: BHP) set a new record and resumed the top spot on the ASX 200.
ASX 200 materials shares rose 2%, and BHP shares finished 2.9% higher at $61.52 after resetting their historical high at $62.30.
The financial sector was the laggard, dropping 4%, largely due to Commonwealth Bank of Australia (ASX: CBA) shares diving 10.4%.
Amid this volatility, brokers have indicated continuing confidence in several ASX 200 shares this week.
Let’s take a look at which stocks have attracted reiterated buy ratings.
Insurance Australia Group Ltd (ASX: IAG)
The IAG share price closed at $7.60, up 1.9% on Wednesday.
Over the past month, this ASX 200 insurance share has risen 4.8%.
UBS renewed its buy rating on IAG shares on Wednesday.
The broker raised its 12-month price target from $8.55 to $8.80.
The target suggests a possible 16% capital gain ahead.Â
National Australia Bank Ltd (ASX: NAB)
The NAB share price finished at $36.86, down 1.5% yesterday.
Over the past month, this ASX 200 bank share has fallen 18%.
UBS renewed its buy rating on NAB shares with a $48.50 target this week.
This implies 31% potential growth ahead.Â
CSL Ltd (ASX: CSL)
The CSL share price closed at $98.79, up 0.2% on Wednesday.
This ASX 200 healthcare giant has fallen 28% in a month and 59% over 12 months.
Morgans renewed its buy rating on CSL shares this week.
However, the broker slashed its price target from $241.34 to $147.59.
This still suggests very healthy upside of 49% over the next year.
ANZ Group Holdings Ltd (ASX: ANZ)
The ANZ share price closed the session yesterday at $34.57, down 1.6%.
Over the past month, this ASX 200 bank share has fallen 11%.
Citi renewed its buy rating on ANZ shares on Tuesday.
The broker trimmed its 12-month price target from $40.30 to $40.
The target suggests a possible 16% capital gain ahead.Â
Pro Medicus Ltd (ASX: PME)
The Pro Medicus share price closed at $125.50, down 0.3% on Wednesday.
This ASX 200 healthcare share has fallen 53% over the past 12 months.
The Pro Medicus share price has been in correction mode after hitting a historical peak of $336 in July 2025.
Canaccord Genuity renewed its buy rating on Pro Medicus shares this week.
The broker lowered its target from $180.82 to $168.62, suggesting a possible 34% upside ahead.Â
Aristocrat Leisure Ltd (ASX: ALL)
The Aristocrat share price closed the session yesterday at $51.94, up 13.3%.
This ASX 200 consumer discretionary share has tumbled 12.9% over six months.
Citi renewed its buy rating on Aristocrat shares with a 12-month target of $65 on Wednesday.
This implies a potential 25% upside ahead.
Temple & Webster Ltd (ASX: TPW)
The Temple & Webster share price closed at $4.98, down 6.4% on Wednesday.
The ASX 200 retail share has fallen 29% in a month and hit a 3-year low of $4.54 yesterday.
Macquarie renewed its buy rating on Temple & Webster shares with a $13.70 target this week.
This implies a potential 173% upside ahead.
Nick Scali Ltd (ASX: NCK)
The Nick Scali share price closed the session yesterday at $14.08, down 2.5%.
Over the past month, this ASX 200 furniture retailer has lost 11% of its valuation.
Macquarie renewed its buy rating on Nick Scali shares with a $21.60 target this week.
This indicates a potential 54% upside ahead.
Metcash Ltd (ASX: MTS)
The Metcash share price closed at $2.97, down 1% on Wednesday.
Over the past six months, this ASX 200 supermarket share has fallen 23%.
UBS renewed its buy rating on Metcash shares with a $3.50 target this week.
This indicates a potential 18% upside ahead.
The post 9 ASX 200 shares with renewed buy calls from the experts this week appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right nowâ¦
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Up 13%: Why this ASX 200 stock is a buy with even more upside
- Are these 2 battered ASX healthcare shares too cheap to ignore?
- These ASX retail stocks are near 52-week lows, are they bargain buys?
- 5 things to watch on the ASX 200 on Thursday
- Why Pro Medicus shares could still have their best years ahead
Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and Temple & Webster Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group, CSL, Nick Scali, Pro Medicus, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.